ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

292
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
14 Jan 2021 19:04

Innovent Biologics Placement - Momentum Is Very Strong but past Deals Have Been Mixed

Innovent Biologics Inc (1801 HK) is looking to raise about U$600m to fund its clinical trials  and product licensing and possible M&A. This will be...

Logo
420 Views
Share
12 Jan 2021 18:52

Ocumension Theraputics Placement - IPO Was Hot, Deal Should Be Supported Despite Lock-Up Expiry

Ocumension Therapeutics (1477 HK) aims to raise around US$103m to commercialize new products, fund clinical trials and develop new facilities.

Logo
273 Views
Share
07 Jan 2021 04:39

Can You Profit from the KR Retail Investor? (Btw You Already Probably Have Met Him)

I wanted to share my thoughts as I follow the retail moves and share not only who the powerful or mover/shaker Korean retail investor as they now...

Logo
385 Views
Share
12 Dec 2020 03:23

Asia Short Interest: BIG Covering in HK & Korea

There was a big drop in short interest in Hong Kong and Korea while shorts rose in Japan mainly led by ANA on the back of the offering. Shorts in...

Logo
339 Views
Share
07 Nov 2020 10:09

Asia Short Interest Weekly: Rising Shorts in HK, Japan and Taiwan

The Asia Short Interest weekly looks at moves in market wide short interest and highlights movements in stock specific short interest that could be...

Logo
318 Views
Share
x